Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Gui-Bin Gao"'
Autor:
Hui-Fang Hu, Gui-Bin Gao, Xuan He, Yu-Ying Li, Yang-Jia Li, Bin Li, YunLong Pan, Yang Wang, Qing-Yu He
Publikováno v:
Journal of Advanced Research, Vol 51, Iss , Pp 135-147 (2023)
Introduction: Acquired resistance to BRAF inhibitor vemurafenib is frequently observed in metastatic colorectal cancer (CRC), and it is a thorny issue that results in treatment failure. As adaptive responses for vemurafenib treatment, a series of cel
Externí odkaz:
https://doaj.org/article/b7dfa0b299f64836815aa3438046b3be
Publikováno v:
Molecular Biomedicine, Vol 2, Iss 1, Pp 1-15 (2021)
Abstract Post-translational modifications (PTMs) of Cyclin-dependent kinase 5 (CDK5) have emerged as important regulatory mechanisms that modulate cancer development in patients. Though CDK5 is an atypical member of the cyclin-dependent kinase family
Externí odkaz:
https://doaj.org/article/4f6dcb8b0d6c43f1853fbc241ac930b7
Autor:
Yang Wang, Jing Zhang, Can‐Can Zheng, Zi‐Jia Huang, Wei‐Xia Zhang, Yun‐Lin Long, Gui‐Bin Gao, Yue Sun, Wen Wen Xu, Bin Li, Qing‐Yu He
Publikováno v:
Clinical and Translational Medicine, Vol 12, Iss 4, Pp n/a-n/a (2022)
Externí odkaz:
https://doaj.org/article/193b58b7bab5468bbba9e3e5b8093150
Autor:
Yang Wang, Yan-Yan Chen, Gui-Bin Gao, Yang-Han Zheng, Nan-Nan Yu, Lan Ouyang, Xuejuan Gao, Nan Li, Shi-Yuan Wen, Shangjia Huang, Qian Zhao, Langxia Liu, Mingrong Cao, Shuixing Zhang, Jing Zhang, Qing-Yu He
Publikováno v:
Molecular Therapy.
Autor:
Hui-Fang, Hu, Gui-Bin, Gao, Xuan, He, Yu-Ying, Li, Yang-Jia, Li, Bin, Li, YunLong, Pan, Yang, Wang, Qing-Yu, He
Publikováno v:
Journal of Advanced Research.
Acquired resistance to BRAF inhibitor vemurafenib is frequently observed in metastatic colorectal cancer (CRC), and it is a thorny issue that results in treatment failure. As adaptive responses for vemurafenib treatment, a series of cellular bypasses
Publikováno v:
Molecular Biomedicine, Vol 2, Iss 1, Pp 1-15 (2021)
Molecular Biomedicine
Molecular Biomedicine
Post-translational modifications (PTMs) of Cyclin-dependent kinase 5 (CDK5) have emerged as important regulatory mechanisms that modulate cancer development in patients. Though CDK5 is an atypical member of the cyclin-dependent kinase family, its abe
Autor:
Zhi-Sheng Ji, Gui-Bin Gao, Yan-Ming Ma, Jian-Xian Luo, Guo-Wei Zhang, Hua Yang, Nan Li, Qing-Yu He, Hong-Sheng Lin
Publikováno v:
Biomaterials. 284
Generation of a promising antioxidative reagent with superior biocompatibility is urgently needed to remedy spinal cord injuries (SCI), repair the damaged neurons and restrain the secondary injuries caused by inflammation-induced oxidative stress. In
Autor:
Jie, Lu, Shuang-Yu, Liu, Jing, Zhang, Guang-Ming, Yang, Gui-Bin, Gao, Nan-Nan, Yu, Yan-Ping, Li, Yi-Xiang, Li, Zhong-Qi, Ma, Yang, Wang, Chun-Hua, Lu
Publikováno v:
Am J Cancer Res
Human hepatocellular carcinoma (HCC) is the most frequent cancer worldwide with a poor prognosis. Tumor-specific pyruvate kinase M2 (PKM2) is essential for cancer metabolism and tumorigenesis. Shikonin, a specific inhibitor of PKM2, but not PKM1, exh
Autor:
Zi-song, Wu, Tian-gui, Wang, Xiao-sheng, Zhang, Bo, Zhong, Liang, Xu, Gui-bin, Gao, Ben-fu, Tan, Yong, Mao, Meng, Tang, Ming-kang, Xie, Wu-li, Yihuo, Shi-zhong, Wang, Chun-hua, Ma, Fa-sen, Xu, Dong-chuan, Qiu
Publikováno v:
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]. 42(8)
To evaluate the effect of snail control through soil pasting mixed with niclosamide.Four sites were selected in different epidemic areas in Sichuan province. Soil pasting mixed with niclosamide was carried on, and the dosage was 0 g/m2, 4 g/m2, 6 g/m